Skip to main content
Veterinary Medicines

Nobilis Rismavac+CA 126 vakcina A.U.V.

Authorised
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live

Product identification

Medicine name:
Nobilis Rismavac+CA 126 vakcina A.U.V.
Active substance:
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
  • Chicken (hen)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
    3.00
    log10 plaque forming unit(s)
    /
    1.00
    unit(s)/dose
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    3.00
    log10 plaque forming unit(s)
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Suspension and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: